HomeHomeHome
Home
TFP - Trifunctional protein deficiency - Condition Details

Trifunctional protein deficiency is an inherited disorder characterized by inadequate levels of an enzyme required to break down long-chain fatty acids. Signs and symptoms may begin during infancy or later in life and include feeding difficulties, hypoglycemia, lethargy, hypotonia, liver problems, heart problems, breathing difficulties, coma, and sudden death. Trifunctional protein deficiency is caused by mutations in the HADHA or HADHB gene; it has an autosomal recessive pattern of inheritance.

Names and Codes

Condition:1 Trifunctional protein deficiency
Abbreviation:1 TFP
Category:2 Core
SNOMED CT Code:3
237999008Mitochondrial trifunctional protein deficiency
UMLS CUI:4C1969443
ICD-9-CM Code:5
277.85Disorders of fatty acid oxidation
ICD-10-CM Code:6
E71.318Other disorders of fatty-acid oxidation

Affected Protein Names and Codes

Enzyme Commission Number:7
1.1.1.211External Web Site PolicyLong-chain-3-hydroxyacyl-CoA dehydrogenase
UniProt Number:8
P40939External Web Site PolicyTrifunctional enzyme subunit alpha, mitochondrial

Analytes or Measurements

These measurements are associated with the condition:

LOINC Long Common Name9 Analyte
Short Name10
LOINC
Number11
Units12
3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in Dried blood spot C10:1OH 53182-2 umol/L
3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in Dried blood spot C12OH 53189-7 umol/L
3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in Dried blood spot C12:1OH 53188-9 umol/L
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Dried blood spot C18:2OH 50109-8 umol/L
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Dried blood spot C18:1OH 50113-0 umol/L
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Dried blood spot C16:1OH 50121-3 umol/L
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Dried blood spot C16OH 50125-4 umol/L
3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot C16OH / C16 53201-0 {ratio}
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Dried blood spot C18OH 50132-0 umol/L
3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in Dried blood spot C14:2OH 53196-2 umol/L
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Dried blood spot C14OH 50281-5 umol/L
3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in Dried blood spot C14:1OH 53197-0 umol/L
Linoleoylcarnitine (C18:2) [Moles/volume] in Dried blood spot C18:2 45217-7 umol/L
Oleoylcarnitine (C18:1) [Moles/volume] in Dried blood spot C18:1 53202-8 umol/L
Palmitoleylcarnitine (C16:1) [Moles/volume] in Dried blood spot C16:1 53198-8 umol/L
Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot C16 53199-6 umol/L
Stearoylcarnitine (C18) [Moles/volume] in Dried blood spot C18 53241-6 umol/L
Tetradecenoylcarnitine (C14:1) [Moles/volume] in Dried blood spot C14:1 53191-3 umol/L

More Information

Additional information is available from Genetics Home Reference13 and from the Online Mendelian Inheritance in Man (OMIM®)14:

Legend

1

Condition Name and Abbreviation — curated by the NLM and selected from among the names used by the Advisory Committee on Heritable Disorders in Newborns and Children (Committee), National Newborn Screening Information System (NNSIS), the American College of Medical Genetics (ACMG), the HHS Office of the National Coordinator for Health Information Technology (ONC)/American Health Information Community (AHIC) Personalized Health Care Work Group, and input from the newborn screening community.

2

Category — based on the U.S. Department of Health and Human Services (HHS) Recommended Uniform Screening Panel. Conditions designated as "core" should be included in every newborn screening program, and "secondary" conditions are some of the disorders that may be detected during screening for a core disorder. Conditions classified as "other" are those that are screened for by some states but are not part of the Recommended Uniform Screening Panel.

3

SNOMED CT® CodeSystematized Nomenclature of Medicine — Clinical Terms code is assigned by the International Health Terminology Standards Development Organisation (IHTSDO). SNOMED CT is a concept-oriented clinical terminology that has been designated as a U.S. standard for electronic health information exchange. The Newborn Screening Coding and Terminology Guide uses some codes from the US Extension to SNOMED CT.

4

UMLS CUI — a concept unique identifier (CUI) assigned to every concept in the Unified Medical Language System (UMLS®).

5

ICD-9-CM CodeInternational Classification of Diseases, Ninth Revision, Clinical Modification code is assigned to diagnoses associated with hospital utilization in the U.S. It is a current US standard for use in administrative healthcare transactions. Although ICD-9-CM codes are fairly specific, in certain cases, the same ICD-9-CM code might apply to several disorders in the same group (e.g. amino acid disorders).

6

ICD-10-CM CodeInternational Classification of Diseases, Tenth Revision, Clinical Modification code. Although ICD-10-CM codes are fairly specific, in certain cases, the same ICD-10-CM code might apply to multiple related disorders.

7

Enzyme Commission (EC) Number — a unique identifier for the affected enzyme (if the affected protein is an enzyme); the EC number is assigned by the Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes by the Reactions they CatalyseExternal Web Site Policy.

8

UniProt Number — a unique identifier assigned to all proteins, including enzymes, hemoglobin subunits, and immunoglobulin chains. The UniProt database is maintained by the Universal Protein ResourceExternal Web Site Policy, an international collaboration.

9

LOINC Long Common Name — derived by the Logical Observation Identifiers Names and CodesExternal Web Site Policy (LOINC®) Committee from the measurement's formal name by using conventional names for analytes and procedures. The long common name eliminates the parts of the formal name that are not needed to distinguish the test from related tests.

10

Analyte Short Name — an abbreviation for the analyte.

11

LOINC Number — the unique and permanent code assigned by the Logical Observation Identifiers Names and CodesExternal Web Site Policy (LOINC®) Committee to identify the test measurement. LOINC codes are unique for different test methods and different units of reporting to enable interoperability and comparison of results from different labs. LOINC is a U.S. government standard for electronic health information exchange of laboratory tests and other measurements in Interoperability Specifications produced by the Healthcare Information Technology Standards Panel (HITSP).

12

Units — what is being counted or measured, using the Unified Code for Units of MeasureExternal Web Site Policy (UCUM). Ratios whose units fully cancel each other are indicated by {Ratio}. UCUM is the US standard for reporting units in laboratory messages. Results that are not quantitative have either a link to the specific LOINC answer list for that analyte or appropriate text (such as "Pos or Neg" or "Specific alleles").

13

Genetics Home Reference — the National Library of Medicine's Web site for consumer-friendly information about genetic conditions and the genes or chromosomes related to those conditions. Visit Genetics Home Reference at http://ghr.nlm.nih.gov/.

14

OMIMOnline Mendelian Inheritance in Man®External Web Site Policy is a comprehensive resource about human genes and genetic diseases. It focuses primarily on the relationship between genotype and phenotype. It is currently maintained by Johns Hopkins University.

Record created: December 19, 2008
Record last updated: January 19, 2016